divestiture
OpGen Sells Customer Contracts, Installed MDx Instrument Base for $218K
The contracts and instrument base was acquired by Singapore-based Camtech, which had previously acquired OpGen's Curetis subsidiary during insolvency proceedings.
Synthego Divests Engineered Cell, CRISPR Guide RNA Business Into Separate Company
Following the move, Synthego intends to focus on therapeutic applications of CRISPR under a newly appointed CEO.
Inex Innovate Acquiring Yourgene Health's Taiwanese Genomics Business for up to $4M
Inex expects Yourgene Taiwan to provide it with additional capabilities in fetal health and oncology R&D, bioinformatics, biobanking, and clinical laboratory services.
The company is selling its applied, food, and enterprise services to New Mountain Capital for $2.45 billion in cash.
Novacyt to Sell Cytology, Clinical Lab Units
The company said it will sell off the businesses in order to focus on in vitro diagnostic product development and its diagnostic reagent units.